Harvard Bioscience, Inc. (HBIO) Improves Q3 EPS to 8c Amid Lower Sales

November 1, 2012 8:59 AM EDT
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q3 EPS of $0.08, versus $0.07 reported last year. Revenue for the quarter came in at $26.1 million, versus $26.4 million reported last year.

For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment